Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity
Posted on: 7 March 2019 , updated on: 8 March 2019
Preprint posted on 18 January 2019
Fatty liver and PPARα: Is it all in the liver? Regnier et al. study the role of hepatic and extrahepatic PPARα in a mouse model of diet-induced obesity
Selected by Pablo Ranea Robles
Categories: biochemistry, cell biology, pathology, physiology
Background
Defects in fatty acid homeostasis in the liver lead to lipotoxic tissue damage, such as hepatosteatosis. PPARα (Peroxisome Proliferator-Activated Receptor Alpha) is a nuclear receptor that plays a key role in metabolic homeostasis, modulating the expression of enzymes involved in fatty acid oxidation. Régnier et al. show in their recent preprint a novel hepatic-specific action of PPARα in the in vivo response against lipid overload (1).
Fatty liver disease is a global health burden. A recent meta analysis calculated a NAFLD (Nonalcoholic Fatty Liver Disease) prevalence of 25% in the global population (2). A characteristic feature of NAFLD is the accumulation of neutral lipids in lipid droplets (Fig 1).
Figure 1. Representative picture of a fatty liver from a NAFLD patient, stained with Masson trichrome staining. Steatosis is demonstrated by the big white “holes”, that are lipid droplets, in which neutral lipids are accumulated to prevent lipotoxicity. Credit: Nephron [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)], from Wikimedia Commons
NASH (Nonalcoholic Steatohepatitis) represents a more severe stage of fatty liver disease not caused by alcohol, characterized by inflammation (hepatitis) and liver cell damage. NASH predisposes patients to much more life-threatening conditions like cirrhosis or hepatocarcinoma. NASH treatment is still an unmet clinical need. Even though dietary and lifestyle modification can reverse fatty liver, unfortunately, few patients manage to achieve the target of weight loss and maintain long-term lifestyle changes. That’s why pharmacological treatment is so important. In order to develop drugs that successfully target NASH progression, it is crucial to identify the molecular players involved in the pathophysiology of this disease.
PPARα is a transcription factor of the family of PPAR nuclear receptors. In metabolically demanding situations, such as fasting or exercise, and upon the binding of endogenous lipids as ligands, PPARα induction promotes the transcription of the enzymatic machinery required for the oxidation of fat. The potential of PPARs’ (alpha, delta, gamma) modulation for the treatment of fatty liver diseases and metabolic disorders is already well known. Wy-14,643, a PPARα-specific agonist, prevents the development of methionine-choline deficient (MCD) diet-induced steatohepatitis (3). However, despite the beneficial effect shown by some drugs such as thiazolidinediones, PPAR agonists have adverse effects or limited potency (4). Whole-body knockout PPARα mice fed with high-fat diet (HFD) or MCD diet, developed more severe steatohepatitis than control animals (5–7). Here, the authors expand the knowledge of the actions of hepatocytic and extrahepatocytic PPARα in the progression of NAFLD in a mouse model of diet-induced obesity. They already showed in a recent report that MCD diet, ageing, and a short-term HFD induce more severe hepatosteatosis in hepatocytic-specific PPARα-deficient mice (8). In this study, the authors induced hepatosteatitis to mice by feeding them 12 weeks with a high-fat diet, and tested the role of hepatic and extrahepatocytic PPARα in this model. To ascertain the role of hepatic/extrahepatic PPARA they employed whole-body (Ppara–/-) and liver-specific Pparα knockout (Pparahep-/-) animals.
Key findings
A first hint on the extrahepatic role of PPARα was demonstrated by the fact that Ppara–/- animals became more overweight than WT and Pparahep-/- animals, even under control diet. This obese phenotype was not due to glucose intolerance, since Ppara-/- and Pparahep-/- did not present fasting hyperglycemia. Liver histology can provide valuable information of steatosis and inflammation in these animals models. The authors observed that HFD exacerbated steatosis in both PPARα-deficient mice much more than in WT animals, depicted by increased number of lipid droplets and hepatic triglycerides. Plasma markers of liver injury, ALT (alanine aminotransferase) and AST (aspartate aminotransferase), were only increased in PPARα-deficient mice fed with a HFD, but not in WT animals. Together, these data show how hepatic PPARα deficiency facilitates the development of hepatosteatitis in the context of obesity.
To better understand the molecular physiology underlying the development of steatosis under HFD in the different genotypes studies, the authors assessed the transcriptome response against HFD in the liver using microarrays. This approach allows to discern the specific changes happening in the liver of hepatic-deficient PPARA mice compared to whole body Ppara-/- mice. They found that only around 5% of the DEGs (differentially expressed genes) sensitive to HFD were regulated independently of hepatocyte or whole-body PPARα. This illustrates the crucial role of this nuclear receptor in the physiological response against a fat-enriched diet. The authors also inferred from this transcriptomic experiment that the response against HFD is different in hepatocyte-deficient PPARα mice and in whole-body PPARα KO mice. These different sets of genes induced or repressed in the different genotypes can shed light on PPARA-regulated responses that can be targeted for NASH treatment. A group of 337 genes were upregulated in Ppara-/- and Pparahep-/- livers, but not in WT, which suggests a negative regulation of these genes by PPARα. Among the enriched KEGG pathways in this set of genes, the authors highlighted inflammatory response, which supports the idea that PPARα is essential to prevent an exacerbated inflammatory response in a high-fat diet environment.
The authors also performed metabolomics in the livers of the different experimental groups, using proton nuclear magnetic resonance (1H-NMR) and targeted lipidomics. With the data obtained, they created a PLS-DA (projection to latent structures for discriminant analysis) model that, again, separated Ppara-/- and Pparahep-/- animals fed with HFD in two different groups, highlighting the role of extrahepatic PPARα in the response against high-fat diet. This extrahepatic PPARα response is also evidenced at the level of lipid metabolism since the lipids measured clustered in different groups depending on the genotype and diet.
What I liked about the study
I liked that the authors used a model (high-fat diet) that is more suited to the problematic of obesity and NASH, rather than other models already tested with a very similar approach.
The employment of two different knockouts (hepatic vs whole-body PPARα knockout), together with the integration of -omics techniques, allows to discern the specific hepatic functions of PPARα versus the extrahepatic functions. This is an important topic in the field, yet to be resolved, but the results of this study cast some light on the role of PPARα in the development of NASH.
Future directions and questions for authors
- Inflammation is a key point in the transition from NAFLD to NASH, but is not clear how the inflammation score in liver images was measured. A more detailed explanation in methods will help a broader audience to understand better how this was done.
- To which point is the transcriptome response in the different experimental groups similar or different to other NASH mouse models, in particular, related to inflammatory response? Here, I’m thinking for example in the recent paper from this group with same genotypes and MCD diet..
- It’s clear with your data that extrahepatic PPARα is crucial for the homeostatic response in the liver against high-fat diet. Do you have any clue which other cell/organ could be important in this response mediated by extrahepatic PPARα?
- The most enriched pathway in the upregulated genes both in Ppara-/- and Pparahep-/- livers, but not in WT, is the lysosome. What do the authors think is the biological significance of this lysosomal “induction”. This is an exciting discovery, given the link of lysosomes and lipid catabolism.
An important aspect that is not remarked by the authors is that the experiments were performed in thermoneutrality. Could the authors elaborate a bit more to the Prelights community on why they chose to perform the experiments in thermoneutrality? What would be the expected result if performed at normal ambient housing temperatures?
References:
- Regnier M, Polizzi A, Smati S, Lukowicz C, Fougerat A, Lippi Y, Fouche E, Lasserre F, Naylies C, Betoulieres C, Barquissau V, Mouisel E, Bertrand-Michel J, Batut A, Saati T Al, Canlet C, Tremblay-Franco M, Ellero-Simatos S, Langin D, et al. (2019) Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity. bioRxiv:488031.
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73–84.
- Ip E, Farrell G, Hall P, Robertson G, Leclercq I (2004) Administration of the potent PPAR? agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39(5):1286–1296.
- Gross B, Pawlak M, Lefebvre P, Staels B (2017) PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol 13(1):36–49.
- Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I (2003) Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38(1):123–132.
- Pawlak M, Baugé E, Bourguet W, De Bosscher K, Lalloyer F, Tailleux A, Lebherz C, Lefebvre P, Staels B (2014) The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice. Hepatology 60(5):1593–1606.
- Abdelmegeed MA, Yoo S-H, Henderson LE, Gonzalez FJ, Woodcroft KJ, Song B-J (2011) PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver. J Nutr 141(4):603–610.
- Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, Lukowicz C, Benhamed F, Iroz A, Bertrand-Michel J, Al Saati T, Cano P, Mselli-Lakhal L, Mithieux G, Rajas F, Lagarrigue S, Pineau T, et al. (2016) Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65(7):1202–1214.
doi: https://doi.org/10.1242/prelights.9231
Read preprint
(No Ratings Yet)Have your say
Sign up to customise the site to your preferences and to receive alerts
Register hereAlso in the biochemistry category:
Triglyceride metabolism controls inflammation and APOE4-associated disease states in microglia
Gustavo Stelzer, Marcus Oliveira
Impaired 26S proteasome causes learning and memory deficiency and induces neuroinflammation mediated by NF-κB in mice
Gustavo Stelzer, Marcus Oliveira
Notch3 is a genetic modifier of NODAL signalling for patterning asymmetry during mouse heart looping
Bhaval Parmar
Also in the cell biology category:
Restoring mechanophenotype reverts malignant properties of ECM-enriched vocal fold cancer
Teodora Piskova
Germplasm stability in zebrafish requires maternal Tdrd6a and Tdrd6c
Justin Gutkowski
Leukocytes use endothelial membrane tunnels to extravasate the vasculature
Felipe Del Valle Batalla
Also in the pathology category:
Integrin conformation-dependent neutrophil slowing obstructs the capillaries of the pre-metastatic lung in a model of breast cancer
Simon Cleary
LINC complex alterations are a hallmark of sporadic and familial ALS/FTD
Megane Rayer et al.
Hypoxia blunts angiogenic signaling and upregulates the antioxidant system in elephant seal endothelial cells
Sarah Young-Veenstra
Also in the physiology category:
Investigating Mechanically Activated Currents from Trigeminal Neurons of Non-Human Primates
Vanessa Ehlers
Geometric analysis of airway trees shows that lung anatomy evolved to enable explosive ventilation and prevent barotrauma in cetaceans
Sarah Young-Veenstra
Precision Farming in Aquaculture: Use of a non-invasive, AI-powered real-time automated behavioural monitoring approach to predict gill health and improve welfare in Atlantic salmon (Salmo salar) aquaculture farms
Jasmine Talevi
preLists in the biochemistry category:
BSCB-Biochemical Society 2024 Cell Migration meeting
This preList features preprints that were discussed and presented during the BSCB-Biochemical Society 2024 Cell Migration meeting in Birmingham, UK in April 2024. Kindly put together by Sara Morais da Silva, Reviews Editor at Journal of Cell Science.
| List by | Reinier Prosee |
Peer Review in Biomedical Sciences
Communication of scientific knowledge has changed dramatically in recent decades and the public perception of scientific discoveries depends on the peer review process of articles published in scientific journals. Preprints are key vehicles for the dissemination of scientific discoveries, but they are still not properly recognized by the scientific community since peer review is very limited. On the other hand, peer review is very heterogeneous and a fundamental aspect to improve it is to train young scientists on how to think critically and how to evaluate scientific knowledge in a professional way. Thus, this course aims to: i) train students on how to perform peer review of scientific manuscripts in a professional manner; ii) develop students' critical thinking; iii) contribute to the appreciation of preprints as important vehicles for the dissemination of scientific knowledge without restrictions; iv) contribute to the development of students' curricula, as their opinions will be published and indexed on the preLights platform. The evaluations will be based on qualitative analyses of the oral presentations of preprints in the field of biomedical sciences deposited in the bioRxiv server, of the critical reports written by the students, as well as of the participation of the students during the preprints discussions.
| List by | Marcus Oliveira et al. |
CellBio 2022 – An ASCB/EMBO Meeting
This preLists features preprints that were discussed and presented during the CellBio 2022 meeting in Washington, DC in December 2022.
| List by | Nadja Hümpfer et al. |
20th “Genetics Workshops in Hungary”, Szeged (25th, September)
In this annual conference, Hungarian geneticists, biochemists and biotechnologists presented their works. Link: http://group.szbk.u-szeged.hu/minikonf/archive/prg2021.pdf
| List by | Nándor Lipták |
Fibroblasts
The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!
| List by | Osvaldo Contreras |
ASCB EMBO Annual Meeting 2019
A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)
| List by | Madhuja Samaddar et al. |
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
| List by | Dey Lab |
Cellular metabolism
A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.
| List by | Pablo Ranea Robles |
MitoList
This list of preprints is focused on work expanding our knowledge on mitochondria in any organism, tissue or cell type, from the normal biology to the pathology.
| List by | Sandra Franco Iborra |
Also in the cell biology category:
November in preprints – the CellBio edition
This is the first community-driven preList! A group of preLighters, with expertise in different areas of cell biology, have worked together to create this preprint reading lists for researchers with an interest in cell biology. Categories include: 1) cancer cell biology 2) cell cycle and division 3) cell migration and cytoskeleton 4) cell organelles and organisation 5) cell signalling and mechanosensing 6) genetics/gene expression
| List by | Felipe Del Valle Batalla et al. |
BSCB-Biochemical Society 2024 Cell Migration meeting
This preList features preprints that were discussed and presented during the BSCB-Biochemical Society 2024 Cell Migration meeting in Birmingham, UK in April 2024. Kindly put together by Sara Morais da Silva, Reviews Editor at Journal of Cell Science.
| List by | Reinier Prosee |
‘In preprints’ from Development 2022-2023
A list of the preprints featured in Development's 'In preprints' articles between 2022-2023
| List by | Alex Eve, Katherine Brown |
preLights peer support – preprints of interest
This is a preprint repository to organise the preprints and preLights covered through the 'preLights peer support' initiative.
| List by | preLights peer support |
The Society for Developmental Biology 82nd Annual Meeting
This preList is made up of the preprints discussed during the Society for Developmental Biology 82nd Annual Meeting that took place in Chicago in July 2023.
| List by | Joyce Yu, Katherine Brown |
CSHL 87th Symposium: Stem Cells
Preprints mentioned by speakers at the #CSHLsymp23
| List by | Alex Eve |
Journal of Cell Science meeting ‘Imaging Cell Dynamics’
This preList highlights the preprints discussed at the JCS meeting 'Imaging Cell Dynamics'. The meeting was held from 14 - 17 May 2023 in Lisbon, Portugal and was organised by Erika Holzbaur, Jennifer Lippincott-Schwartz, Rob Parton and Michael Way.
| List by | Helen Zenner |
9th International Symposium on the Biology of Vertebrate Sex Determination
This preList contains preprints discussed during the 9th International Symposium on the Biology of Vertebrate Sex Determination. This conference was held in Kona, Hawaii from April 17th to 21st 2023.
| List by | Martin Estermann |
Alumni picks – preLights 5th Birthday
This preList contains preprints that were picked and highlighted by preLights Alumni - an initiative that was set up to mark preLights 5th birthday. More entries will follow throughout February and March 2023.
| List by | Sergio Menchero et al. |
CellBio 2022 – An ASCB/EMBO Meeting
This preLists features preprints that were discussed and presented during the CellBio 2022 meeting in Washington, DC in December 2022.
| List by | Nadja Hümpfer et al. |
Fibroblasts
The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!
| List by | Osvaldo Contreras |
EMBL Synthetic Morphogenesis: From Gene Circuits to Tissue Architecture (2021)
A list of preprints mentioned at the #EESmorphoG virtual meeting in 2021.
| List by | Alex Eve |
FENS 2020
A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020
| List by | Ana Dorrego-Rivas |
Planar Cell Polarity – PCP
This preList contains preprints about the latest findings on Planar Cell Polarity (PCP) in various model organisms at the molecular, cellular and tissue levels.
| List by | Ana Dorrego-Rivas |
BioMalPar XVI: Biology and Pathology of the Malaria Parasite
[under construction] Preprints presented at the (fully virtual) EMBL BioMalPar XVI, 17-18 May 2020 #emblmalaria
| List by | Dey Lab, Samantha Seah |
1
Cell Polarity
Recent research from the field of cell polarity is summarized in this list of preprints. It comprises of studies focusing on various forms of cell polarity ranging from epithelial polarity, planar cell polarity to front-to-rear polarity.
| List by | Yamini Ravichandran |
TAGC 2020
Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20
| List by | Maiko Kitaoka et al. |
3D Gastruloids
A curated list of preprints related to Gastruloids (in vitro models of early development obtained by 3D aggregation of embryonic cells). Updated until July 2021.
| List by | Paul Gerald L. Sanchez and Stefano Vianello |
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
| List by | Hiral Shah |
ASCB EMBO Annual Meeting 2019
A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)
| List by | Madhuja Samaddar et al. |
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
| List by | Dey Lab |
Autophagy
Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.
| List by | Sandra Malmgren Hill |
Lung Disease and Regeneration
This preprint list compiles highlights from the field of lung biology.
| List by | Rob Hynds |
Cellular metabolism
A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.
| List by | Pablo Ranea Robles |
BSCB/BSDB Annual Meeting 2019
Preprints presented at the BSCB/BSDB Annual Meeting 2019
| List by | Dey Lab |
Biophysical Society Annual Meeting 2019
Few of the preprints that were discussed in the recent BPS annual meeting at Baltimore, USA
| List by | Joseph Jose Thottacherry |
ASCB/EMBO Annual Meeting 2018
This list relates to preprints that were discussed at the recent ASCB conference.
| List by | Dey Lab, Amanda Haage |
Also in the pathology category:
Fibroblasts
The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!
| List by | Osvaldo Contreras |
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
| List by | Hiral Shah |
COVID-19 / SARS-CoV-2 preprints
List of important preprints dealing with the ongoing coronavirus outbreak. See http://covidpreprints.com for additional resources and timeline, and https://connect.biorxiv.org/relate/content/181 for full list of bioRxiv and medRxiv preprints on this topic
| List by | Dey Lab, Zhang-He Goh |
1
Cellular metabolism
A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.
| List by | Pablo Ranea Robles |
Also in the physiology category:
Fibroblasts
The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!
| List by | Osvaldo Contreras |
FENS 2020
A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020
| List by | Ana Dorrego-Rivas |
TAGC 2020
Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20
| List by | Maiko Kitaoka et al. |
Autophagy
Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.
| List by | Sandra Malmgren Hill |
6 years
herve Guillou
Dear Pablo,
Many thanks for your constructive review.
We are currently revising the manuscript and will consider your review to improve the manuscript.
All the best,
Hervé